Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exophthalmos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT05049603
What this trial is testing

Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Who this might be right for
Graves' Orbitopathy
University of Pisa 102
Very early researchLooking for participantsNCT07129642
What this trial is testing

Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease

Who this might be right for
Graves Disease
Shanghai Zhongshan Hospital 5
Post-approval studies (Phase 4)Study completedNCT00917241
What this trial is testing

Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone

Who this might be right for
Graves' Disease
Xiao-Ming Mao 218
Large-scale testing (Phase 3)Study completedNCT06269393
What this trial is testing

IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
Peking University People's Hospital 53
Not applicableStudy completedNCT05945784
What this trial is testing

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Who this might be right for
Stroke, IschemicStroke HemorrhagicStroke (CVA) or TIA+11 more
Casa Colina Hospital and Centers for Healthcare 57
Large-scale testing (Phase 3)Not Yet RecruitingNCT07622121
What this trial is testing

Treatment of Chronic Thyroid Eye Disease With MHB018A

Who this might be right for
Thyroid Eye Disease, TED
Minghui Pharmaceutical (Hangzhou) Ltd 135
Testing effectiveness (Phase 2)Ended earlyNCT03938545
What this trial is testing

ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

Who this might be right for
Graves' Ophthalmopathy (GO)
Immunovant Sciences GmbH 65
Not applicableStudy completedNCT03009357
What this trial is testing

Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis

Who this might be right for
ThyrotoxicosisGraves DiseaseThyroiditis
Seoul National University Bundang Hospital 40
Not applicableLooking for participantsNCT07381413
What this trial is testing

Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy

Who this might be right for
Thyroid Associated OphthalmopathiesEye Tracking
Shanghai Changzheng Hospital 100
Not applicableStudy completedNCT03590080
What this trial is testing

Impact of Intravenous Methylprednisolone Treatment on Blood Pressure

Who this might be right for
Graves DiseaseGraves OphthalmopathyHypertension+2 more
Medical University of Warsaw 32
Large-scale testing (Phase 3)Study completedNCT05176639
What this trial is testing

A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 113
Large-scale testing (Phase 3)Not Yet RecruitingNCT07620405
What this trial is testing

Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Minghui Pharmaceutical (Hangzhou) Ltd 219
Large-scale testing (Phase 3)Study completedNCT06179875
What this trial is testing

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 139
Large-scale testing (Phase 3)Study completedNCT07155668
What this trial is testing

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 87
Post-approval studies (Phase 4)Study completedNCT01458600
What this trial is testing

Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)

Who this might be right for
Graves´ Disease
Mikael Lantz 65
Not applicableStudy completedNCT00432146
What this trial is testing

Effect of Lugol's Solution in the Patients With Graves' Disease

Who this might be right for
Graves Disease
Istanbul University 36
Post-approval studies (Phase 4)Study completedNCT00946296
What this trial is testing

Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease

Who this might be right for
Graves DiseaseHyperthyroidism
University of Massachusetts, Worcester 36
Not applicableNot Yet RecruitingNCT07623837
What this trial is testing

Clinical Validation of AI-Based Quantitative Eye Movement Analysis From Smartphone 9-Gaze Videos (Glandy EOM)

Who this might be right for
Ocular Motility DisordersStrabismusExtraocular Muscle Dysfunction+1 more
THYROSCOPE INC. 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07462130
What this trial is testing

An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Nanjing Chia-tai Tianqing Pharmaceutical 74
Not applicableStudy completedNCT02798965
What this trial is testing

Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study

Who this might be right for
Graves Disease
Centre Hospitalier Universitaire, Amiens 52
Next Page